After a course of combination platinum- and taxol-based treatment (carboplatin and paclitaxel), IgA levels in response to HSF1-PO4 increased considerably, establishing HSF1-PO4 as a possible tumor-associated antigen [47]. The gene discussed is HSF1; the disease is neoplasm.